Login / Signup
Tildrakizumab in the treatment of PASH syndrome: A potential novel therapeutic target.
Yonatan Kok
Jenny Nicolopoulos
George Varigos
Anne Howard
Con Dolianitis
Published in:
The Australasian journal of dermatology (2020)
Keyphrases
</>
case report
risk assessment
combination therapy
human health
replacement therapy